Thomas Kuilman
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Enabling next-generation engineered TCR-T therapies based on high-throughput TCR discovery from diagnostic tumor biopsies.
Journal: Nature communications
Published: September 09, 2024
The Elongin BC Complex Negatively Regulates AXL and Marks a Differentiated Phenotype in Melanoma.
Journal: Molecular cancer research : MCR
Published: August 17, 2022
An adverse tumor-protective effect of IDO1 inhibition.
Journal: Cell reports. Medicine
Published: April 01, 2022
RNF31 inhibition sensitizes tumors to bystander killing by innate and adaptive immune cells.
Journal: Cell reports. Medicine
Published: October 22, 2021
Predictive Immune-Checkpoint Blockade Classifiers Identify Tumors Responding to Inhibition of PD-1 and/or CTLA-4.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 29, 2020
Presence of a 34-gene signature is a favorable prognostic marker in squamous non-small cell lung carcinoma.
Journal: Journal of translational medicine
Published: April 29, 2020
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.
Journal: Cell
Published: January 25, 2020
Absence of PD-L1 expression on tumor cells in the context of an activated immune infiltrate may indicate impaired IFNγ signaling in non-small cell lung cancer.
Journal: PloS one
Published: October 26, 2018
Augmenting Immunotherapy Impact by Lowering Tumor TNF Cytotoxicity Threshold.
Journal: Cell
Published: May 24, 2018
XenofilteR: computational deconvolution of mouse and human reads in tumor xenograft sequence data.
Journal: BMC bioinformatics
Published: February 16, 2018
Phenotypic diversity drives paracrine drug tolerance.
Journal: EMBO molecular medicine
Published: July 12, 2017
Last Updated: 09/26/2026